Word mark

Trademark: 'AMYREX' 
Mindset Biopharmaceuticals (USA) Inc
European Community Trademark, no. 001157858, Word mark


On 30. 4. 1999 the community trademark application no. 001157858 was filed for AMYREX (Word mark) by Mindset Biopharmaceuticals (USA) Inc before the OAMI.The goods and services in respect of which registration of the trademark was sought are in classes 5 and 42. The current status of the trademark is application refused.

Status is 'Application refused'
The Community Trade Mark application has been rejected during the registration phase. The refusal may be based on formalities, classification, absolute grounds or relative grounds, i.e. as a result of an opposition.

Applied30. 4. 1999
Nice classes5, 42


You can follow this trademark. You will receive an email, whenever we detect changes of the trademark filing.
This service is for free. You can unsubsribve whenever you want. More information.



Mindset Biopharmaceuticals (USA) Inc
c/o Miller & Canfield 1450 Broadway, 41st Floor
10018 New York,


If you are the trademark owner and the data above are not correct, then please update them soon by clicking on Update address.

If you want to transfer the trademark to another owner, click on Transfer trademark.

You can transfer a trademark partially or completely to another owner. A partial transfer means that you can transfer a trademark in specific classes.

Still questions? Call us : 0049 (0) 89 6666 10 89


15 Clare Road
HX1 2HY Halifax,


If the data above is not correct, then please choose Update.


Nice classes

5  Pharmaceutical preparations; antibody preparations; monoclonal antibodies; biological preparations; biological cultures; cell cultures; cell lines; chemical preparations; cultures of micro organisms; diagnostic preparations; enzymes; genes; proteins; recombinant antibodies; vaccines; all of the above foresaid goods being for the diagnosis or treatment of amyloidosis.

42  Scientific, medical and industrial research, all relating to amyloidosis; biochemical analysis and biochemical research both relating to amyloidosis; diagnosis of predisposition to amyloidosis; amyloidosis disease management; amyloidosis drug design; amyloidosis health care; prophylaxis and treatment of medical disorders all relating to amyloidosis; vaccination and treatment of amyloidosis patients.


Records history

19.1.2017 The current state is Application refused
Current state
16.11.2001 Registered
Representative - Appointement of a new representative
15.11.2001 Published
Proprietor - Total transfers
30.4.1999 Application
Application of the trademark 001157858 AMYREX

Further trademarks of the owner